News

Advocacy in Action Award & The “Paola Gonzato Memory Award” 2025

🏆 2025 Advocacy in Action Awards - Recognizing Excellence in Sarcoma Advocacy Projects SPAGN is proud to announce the recipients of the 2025 Advocacy in Action Awards, presented during the SPAGN Annual Conference 2025. These awards celebrate innovative and impactful...
Read More ... about Advocacy in Action Award & The “Paola Gonzato Memory Award” 2025

EURACAN Launches New Website – Share Your Feedback!

🆕 EURACAN has recently launched its new website, designed to enhance accessibility and provide valuable resources for the sarcoma community. We invite you to explore the site and let us know your thoughts! 🌐 Visit the new EURACAN website HERE. ...
Read More ... about EURACAN Launches New Website – Share Your Feedback!

Exciting News: FDA Approves Vimseltinib for TGCT!

The FDA has officially approved vimseltinib for the treatment of symptomatic tenosynovial giant cell tumor (TGCT), a rare, non-malignant tumor that affects joints, tendons, and the synovial lining. This condition can cause pain, swelling, and reduced mobility, significantly impacting patients'...
Read More ... about Exciting News: FDA Approves Vimseltinib for TGCT!

Global Insights on Sarcoma Diagnosis: Preliminary Findings from SPAGN’s Survey

The Sarcoma Patients Advocacy Global Network (SPAGN) is shedding light on the complex and often lengthy journey to a correct sarcoma diagnosis through its Global Survey on Sarcoma Diagnosis Pathways. This initiative aims to capture real-world patient experiences worldwide. At...
Read More ... about Global Insights on Sarcoma Diagnosis: Preliminary Findings from SPAGN’s Survey

Tools Anyone Can Use: Become a Social Media Superhero

Creating impactful social media content is essential for patient advocacy groups, but it can often feel like a time-consuming challenge. SPAGN, in collaboration with New Horizons GIST, is hosting a special webinar to empower advocates with tools that simplify and...
Read More ... about Tools Anyone Can Use: Become a Social Media Superhero

“SPAGN Advocacy in Action Award 2025” & “Paola Gonzato Memory Award”

Call for Nominations  SPAGN is thrilled to announce the opening of nominations for the prestigious Advocacy in Action Award 2025 and the newly introduced Paola Gonzato Memory Award for impactful projects in sarcoma patient advocacy.   Advocacy in Action Award...
Read More ... about “SPAGN Advocacy in Action Award 2025” & “Paola Gonzato Memory Award”

SPAGN Annual Conference 2025

We are thrilled to announce that the SPAGN Annual Conference 2025 will be held in Washington D.C., USA, from April 11-13, 2025. This will be our first conference in the United States, marking a significant milestone for our global community....
Read More ... about SPAGN Annual Conference 2025

Patient Advocacy @CTOS 2024

  We are delighted to announce that patient advocacy will once again have a valued presence at the Connective Tissue Oncology Society (CTOS) Annual Meeting. This year, we are pleased to host the Patient Advocacy Lounge at CTOS 2024 in San Diego:...
Read More ... about Patient Advocacy @CTOS 2024

ACF’s European Manifesto: Addressing Critical Gaps in Research and Treatment of Rare Cancers🎗️

The Anticancer Fund (ACF) has launched its European Manifesto 2024, presenting a forward-looking strategy to position Europe as a global leader in cancer treatment innovation. With cancer rates set to rise dramatically-35 million new cases projected by 2050-there's no time...
Read More ... about ACF’s European Manifesto: Addressing Critical Gaps in Research and Treatment of Rare Cancers🎗️

Key Findings from Phase II of the SPAGN Priority Setting Partnership published 📝

The Sarcoma Patient Advocacy Global Network (SPAGN) has published the results of the second phase of its Priority Setting Partnership (PSP), focusing on identifying research and patient advocacy priorities in sarcoma care, in "BMC Cancer". This initiative is groundbreaking as...
Read More ... about Key Findings from Phase II of the SPAGN Priority Setting Partnership published 📝